Becoming an Oncologist: Education and Training Pathway

The path to practicing oncology in the United States spans a minimum of 13 years of post-secondary education and clinical training, encompassing undergraduate preparation, medical school, residency, and subspecialty fellowship. This page details each phase of that pathway, the credentialing bodies that govern it, and the decision points where trainees commit to a specific oncology discipline. Understanding the full structure matters for prospective physicians, advisors, and patients seeking to understand the qualifications behind their care teams.

Definition and Scope

Oncology is a recognized medical subspecialty, not a primary medical degree or standalone residency track. A physician practicing oncology holds both a base specialty board certification — in internal medicine, radiation medicine, surgery, pediatrics, or gynecology, depending on discipline — and a subspecialty certification in an oncology field issued by the American Board of Medical Specialties (ABMS) through one of its 24 member boards.

The Accreditation Council for Graduate Medical Education (ACGME) accredits the residency and fellowship programs that constitute graduate medical education in the United States. ACGME program requirements define minimum case volumes, supervision standards, and clinical competency milestones for each training stage. Physicians who pursue oncology must satisfy ACGME requirements at the residency level before becoming eligible for fellowship training.

The scope of oncology education spans three broad discipline tracks — medical oncology (systemic treatment), radiation oncology, and surgical oncology — each with distinct training architectures described in the sections below. A fourth track, pediatric oncology, follows a parallel structure through the American Board of Pediatrics. The types of oncologists page maps these discipline boundaries in clinical terms.

How It Works

The training pathway follows a fixed sequential structure with limited flexibility in ordering.

Phase 1: Undergraduate Education (4 years)
No specific undergraduate major is required by medical schools, but prerequisite coursework established by the Association of American Medical Colleges (AAMC) includes general biology, general and organic chemistry, physics, biochemistry, mathematics, and English composition. Most competitive applicants complete a bachelor's degree in a biological science. MCAT scores, research experience, and clinical hours factor into admissions decisions.

Phase 2: Medical School (4 years)
Medical Doctor (MD) programs accredited by the Liaison Committee on Medical Education (LCME) follow a 2+2 structure: 2 years of preclinical sciences followed by 2 years of clinical rotations. Doctor of Osteopathic Medicine (DO) programs are accredited by the Commission on Osteopathic College Accreditation (COCA). Both MD and DO graduates are eligible for ACGME-accredited residency programs. Students interested in oncology typically pursue elective rotations in hematology, oncology clinics, and radiation medicine during the third and fourth years.

Phase 3: Residency (3–5 years)
The residency stage is where the career path branches by discipline:

  1. Medical Oncology / Hematology-Oncology — Requires completion of a 3-year internal medicine residency, after which the physician applies to a hematology-oncology fellowship (typically 3 years).
  2. Radiation Oncology — Requires a 1-year transitional or preliminary year followed by a 4-year radiation oncology residency. This is a direct specialty track under ACGME Program Requirements for Radiation Oncology. Details are covered on the radiation oncology residency page.
  3. Surgical Oncology — Requires completion of a 5-year general surgery residency, followed by a 2-year surgical oncology fellowship accredited through the Society of Surgical Oncology (SSO) and ACGME.
  4. Gynecologic Oncology — Requires a 4-year obstetrics and gynecology residency followed by a 3–4 year gynecologic oncology fellowship, with board certification through the American Board of Obstetrics and Gynecology (ABOG).
  5. Pediatric Oncology — Requires a 3-year pediatrics residency followed by a 3-year pediatric hematology-oncology fellowship, with certification through the American Board of Pediatrics (ABP).

Phase 4: Fellowship (2–3 years)
Fellowship training provides subspecialty clinical and research depth. ACGME minimum program requirements for medical oncology fellowships mandate a defined case mix including solid tumors and hematologic malignancies, palliative care exposure, and scholarly activity. Fellowship completion makes the physician eligible to sit for subspecialty board examinations.

Phase 5: Board Certification
The medical oncology board certification process through the American Board of Internal Medicine (ABIM) requires successful completion of an accredited fellowship and passage of the Medical Oncology Certification Examination. Maintenance of certification (MOC) involves ongoing assessments every 10 years under ABIM's current framework.

Common Scenarios

Three divergent scenarios illustrate how trainees enter oncology practice:

Scenario A — Community Medical Oncologist: Completes internal medicine residency at a community hospital, matches into a hematology-oncology fellowship at an academic center, earns ABIM subspecialty certification, and joins a private or hospital-employed outpatient practice. This accounts for the majority of practicing oncologists in the United States by practice setting, per the American Society of Clinical Oncology (ASCO) workforce data.

Scenario B — Academic Radiation Oncologist: Enters a dedicated radiation oncology residency after a transitional year, pursues a research-intensive program with dosimetry and physics exposure, completes a disease-site fellowship (e.g., CNS or prostate), and joins a university-based department integrating clinical trials with patient care. The regulatory framing governing radiation safety in these settings is detailed at /regulatory-context-for-oncology.

Scenario C — Surgical Oncologist with Complex Tumor Focus: Completes 5 years of general surgery residency, pursues an SSO-accredited surgical oncology fellowship with hepato-pancreato-biliary (HPB) or sarcoma emphasis, and practices at a comprehensive cancer center designated by the National Cancer Institute (NCI).

Decision Boundaries

Trainees face 4 critical branch points where choices constrain future options:

  1. Medical school application (undergraduate): Choosing MD vs. DO affects program access in limited ways, though ACGME merger of accreditation systems in 2020 substantially equalized residency eligibility.
  2. Residency match (medical school Year 4): The choice between internal medicine, general surgery, radiation oncology, obstetrics-gynecology, or pediatrics locks the oncology subspecialty pathway. Cross-track movement after residency completion is exceptionally rare and generally requires repeating training.
  3. Fellowship match (post-residency): Within hematology-oncology, applicants may signal interest in solid tumor oncology, pure hematology, or combined tracks. Program selection also influences academic vs. community career trajectory.
  4. Board certification scope: Physicians holding both hematology and medical oncology certification (ABIM dual-pathway) may practice across malignant and non-malignant hematologic disease, a broader scope than medical oncology certification alone. This distinction is relevant when reviewing oncology practice models.

Physicians exploring the full breadth of clinical oncology roles — including the distinction between subspecialties — can reference the subspecialties of oncology page and the site's main oncology authority index for structured navigation of related content areas.

References

The law belongs to the people. Georgia v. Public.Resource.Org, 590 U.S. (2020)